P826 Economic impact of inflamatory bowel disease in Catalonia. A population-based analysis

Abstract Background Background: Inflammatory Bowel Disease (IBD) has an important economic impact in healthcare costs and resources utilization. Population data on this topic are scarce. The aim of study was to evaluate the current expenditures IBD a population-wide Catalonia. Methods Methods: All patients with included Catalan Health Surveillance System (CHSS) were included. CHSS includes more than 7 million individuals 2020, 34,823 them being diagnosed IBD. Data prevalence, incidence, comorbidities, stratification risk, use extracted from according ICD-10-CM codes. expenditure calculated standard each service provided by Department (Generalitat de Catalunya). utilization services associated compared control group not identified as adjusted age, sex, income level (hereinafter referred “non-IBD”). separately for Crohn’s (CD) Ulcerative Colitis (UC). Results Results: prevalence incidence 2020 405.6 27.2 per 100,000 inhabitants, respectively. Total number 37,381. Prevalence comorbidities (neoplasia, arthritis, chronic obstructive pulmonary disease, asthma, cardiac ictus mental disease) higher patients’ when non-IBD population. risk hospitalization twice those individuals. global patient 164M€. average annual 4M€ versus 1M€ population; 3.4-fold higher. Cost UC 3,360€ 5,699€ CD patient. Conclusion Conclusion: Patients presented (1.5-2 fold) Healthcare approximately 3.4 times